Browse > Article
http://dx.doi.org/10.17245/jdapm.2021.21.3.261

An anesthetic management of head and neck cancer reconstructive surgery in a patient having hemophilia A: a case report  

Ryoo, Seung-Hwa (Department of Dental Anesthesiology, School of Dentistry, Seoul National University)
Kwon, Dohyun (Department of Oral and Maxillofacial Surgery, School of Dentistry, Seoul National University)
Lee, Jong-Ho (Department of Oral and Maxillofacial Surgery, School of Dentistry, Seoul National University)
Seo, Kwang-Suk (Department of Dental Anesthesiology, School of Dentistry, Seoul National University)
Kim, Hyun Jeong (Department of Dental Anesthesiology, School of Dentistry, Seoul National University)
Karm, Myong-Hwan (Department of Dental Anesthesiology, School of Dentistry, Seoul National University)
Publication Information
Journal of Dental Anesthesia and Pain Medicine / v.21, no.3, 2021 , pp. 261-268 More about this Journal
Abstract
Hemophilia A is a hemorrhagic disease caused by coagulation factor VIII deficiency. In head and neck cancer surgery, especially during a reconstructive one, complications can occur. These include hematomas due to bleeding which can then lead to flap ischemia, necrosis, and impaired wound healing. There are fewer cases of reconstructive surgery in patients with hemophilia A. Here in we report, a reconstructive surgery that involved mass resection, partial glossectomy (right), selective neck dissection (right, Levels I, II, III, IV), and reconstruction at the lateral arm free flap (left) in a 25-year-old man with hemophilia A. The surgery was successfully performed without any complications after pretreatment with Factor VIII concentrate, which has not been reported earlier.
Keywords
Factor VIII; Hemophilia A; Reconstructive Surgical Procedures; Squamous Cell Carcinoma of Head and Neck;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Pollei TR, Hinni ML, Moore EJ, Hayden RE, Olsen KD, Casler JD, et al. Analysis of postoperative bleeding and risk factors in transoral surgery of the oropharynx. JAMA Otolaryngol Head Neck Surg 2013; 139: 1212-8.   DOI
2 Kerawala CJ, Heliotos M. Prevention of complications in neck dissection. Head Neck Oncol 2009; 1: 35.   DOI
3 Malgonde M, Kumar M. Complications after neck dissection. Medical Journal of Dr DY Patil University 2015; 8: 458-62.   DOI
4 Wang KY, Yang KC, Su FY, Chen YC, Hsieh YH, Huang SL, et al. Association between blood pressure and postoperative hematomas in the patients undergoing head and neck cancer reconstruction. Head Neck 2019; 41: 3241-6.   DOI
5 Srivastava A, Santagostino E, Dougall A, Kitchen S, Sutherland M, Pipe SW, et al. WFH guidelines for the management of hemophilia, 3rd edition. Haemophilia 2020; 26: 1-158.   DOI
6 Castaman G, Matino D. Hemophilia A and B: molecular and clinical similarities and differences. Haematologica 2019; 104: 1702-9.   DOI
7 Hoyer LW. Hemophilia a. N Engl J Med 1994; 330: 38-47.   DOI
8 Shastry SP, Kaul R, Baroudi K, Umar D. Hemophilia A: dental considerations and management. J Int Soc Prev Community Dent 2014; 4: S147-52.   DOI
9 Winter WE, Flax SD, Harris NS. Coagulation testing in the core laboratory. Lab Med 2017; 48: 295-313.   DOI
10 Franchini M, Zaffanello M, Lippi G. The use of desmopressin in mild hemophilia A. Blood Coagul Fibrinolysis 2010; 21: 615-9.   DOI
11 Ljung RC, Knobe K. How to manage invasive procedures in children with haemophilia. Br J Haematol 2012; 157: 519-28.   DOI
12 Collins PW, Bjorkman S, Fischer K, Blanchette V, Oh M, Schroth P, et al. Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens. J Thromb Haemost 2010; 8: 269-75.   DOI
13 Laino L, Cicciu M, Fiorillo L, Crimi S, Bianchi A, Amoroso G, et al. Surgical risk on patients with coagulopathies: guidelines on hemophiliac patients for oro-maxillofacial surgery. Int J Environ Res Public Health 2019; ; 16: 1386.   DOI
14 Manco-Johnson MJ, Abshire TC, Shapiro AD, Riske B, Hacker MR, Kilcoyne R, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535-44.   DOI
15 Gringeri A, Lundin B, von Mackensen S, Mantovani L, Mannucci PM. A randomized clinical trial of prophylaxis in children with hemophilia A (the esprit study). J Thromb Haemost 2011; 9: 700-10.   DOI
16 Zimmerman B, Valentino LA. Hemophilia: in review. Pediatr Rev 2013; 34: 289-94.   DOI
17 Mansouritorghabeh H. Clinical and laboratory approaches to hemophilia A. Iran J Med Sci 2015; 40: 194-205.
18 Peyvandi F, Kenet G, Pekrul I, Pruthi RK, Ramge P, Spannagl M. Laboratory testing in hemophilia: impact of factor and non-factor replacement therapy on coagulation assays. J Thromb Haemost 2020; 18: 1242-55.   DOI
19 Pereira CM, Figueiredo ME, Carvalho R, Catre D, Assuncao JP. Anesthesia and surgical microvascular flaps. Rev Bras Anestesiol 2012; 62: 563-79.   DOI
20 White GC 2nd, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the international society on thrombosis and haemostasis. Thromb Haemost 2001; 85: 560.   DOI
21 Evatt BL. The natural evolution of haemophilia care: developing and sustaining comprehensive care globally. Haemophilia 2006; 12: 13-21.   DOI